P006 Innovative Practice Management Pearls in Dermatology
DESCRIPTION
Medicine is one of the largest Businesses in the world. Most medical training does not involve learning about this important topic. In this session Dermatologists and trainees will learn about innovation in various aspects of Business and Leadership in Medicine and Dermatology.
LEARNING OBJECTIVES
Describe various innovations in business of Dermatology and Medicine
Outline various practice settings for Dermatologists and Trainees and how to improve it with innovative approaches
Describe innovation in leadership: “Perspectives from AAD and AMA”
SCHEDULE
1:00 PM
Pearls for Running a Successful Medical Dermatology Practice
Amy J. McMichael, MD, FAAD
1:15 PM
Pearls for Running a Successful Dermatopathology Practice
Alina G. Bridges, DO, FAAD
1:30 PM
Pearls for Running a Successful Surgical Dermatology Practice
Martha Laurin Council, MD, MA, MBA, FAAD
1:45 PM
Pearls for Running a Successful Pediatric Dermatology Practice
Fernanda Bellodi Schmidt, MD
2:00 PM
Pearls for Starting and Running a Solo Dermatology Practice
Natalie M. Curcio, MD, MPH, FAAD
2:15 PM
Pearls in Teledermatology
George Han, MD, PhD, FAAD
2:30 PM
Pearls in Artificial Intelligence Applications in Dermatology
Faranak Kamangar, MD, FAAD
2:45 PM
Q&A
DIRECTOR
Keyvan Nouri, MBA, MD, FAAD
SPEAKERS
Fernanda Bellodi Schmidt, MD
University of Miami
Alina G. Bridges, DO, FAAD
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Martha Laurin Council, MD, MA, MBA, FAAD
Washington University in St. Louis
Natalie M. Curcio, MD, MPH, FAAD
Vanderbilt University School of Medicine
George Han, MD, PhD, FAAD
Icahn School of Medicine at Mount Sinai
Faranak Kamangar, MD, FAAD
DermGPT
Amy J. McMichael, MD, FAAD
Wake Forest University School of Medicine
DISCLOSURES
Fernanda Bellodi Schmidt, MD
Abeona Therapeutics – Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding); Primus Pharmaceuticals – Advisory Board(Honoraria); Timber Pharmaceuticals – Investigator(Grants/Research Funding);
Alina G. Bridges, DO, FAAD
No financial relationships exist with ineligible companies.
Martha Laurin Council, MD, MA, MBA, FAAD
Castle Biosciences – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Sanofi/Regeneron – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Natalie M. Curcio, MD, MPH, FAAD
DefenAge – Advisory Board(Stock), Speaker(Equipment); Revance Therapeutics, Inc. – Investigator(Fees);
George Han, MD, PhD, FAAD
Alumis – Investigator(Grants/Research Funding); Avillion – Investigator(Grants/Research Funding); Boehringer Ingelheim – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Advisory Board(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Incyte Corporation – Advisory Board(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); LearnHealth/LearnSkin – Speaker/Faculty Education(Honoraria); Leo Pharma – Advisory Board(Honoraria); Novartis Pharmaceuticals Corp. – Investigator(Grants/Research Funding); Ortho Dermatologics – Advisory Board(Honoraria); Pfizer Inc. – Speaker(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria); Sanofi Genzyme – Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Speaker(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); UCB – Advisory Board(Honoraria), Speaker(Honoraria);
Faranak Kamangar, MD, FAAD
No financial relationships exist with ineligible companies.
Amy J. McMichael, MD, FAAD
Aclaris Therapeutics Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Allergan, Inc. – Consultant(Honoraria); Apogee BioPharm – Advisory Board(No Compensation Received); Arcutis Biotherapeutics – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria); Canfield Scientific, Inc. – Consultant (1099 relationship)(Honoraria); Cassiopea S.p.A. – Investigator(Grants/Research Funding); CeraVe/Valeante – Consultant(Honoraria); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant (1099 relationship)(Honoraria); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Galderma Laboratories, L.P. – Consultant(Other Financial Benefit); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding); Informa – Other(Other Financial Benefit); JAMA – Other(No Compensation Received); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); Johnson & Johnson Consumer Products Company – Consultant(Honoraria); Kenvue – Consultant (1099 relationship)(Honoraria); L'Oreal USA Inc. – Advisory Board(Honoraria); LearnHealth/LearnSkin – Speaker/Faculty Education(Honoraria); Leo Pharma – Consultant (1099 relationship)(Honoraria); McGraw-Hill Companies – Other(Patent royalties or other compensation for Intellectual Property Rights); NAAF – Advisory Board(No Compensation Received); North American Hair Research Society – Board of Directors(No Compensation Received); Nutrafol – Advisory Board(Honoraria); Pelage Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria), Consultant(Other Financial Benefit); Procter & Gamble Company – Consultant(Honoraria), Investigator(Other Financial Benefit); Revian LTD. – Board of Directors(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria); UpToDate, Inc – Speaker/Faculty Education(Honoraria); VeraDermics Inc. – Consultant (1099 relationship)(Honoraria);
Keyvan Nouri, MBA, MD, FAAD
iVeena Delivery Systems-Eye Drug Delivery – Stockholder(No Compensation Received); Pfizer Inc. – Stockholder(No Compensation Received);